Programming Neonate Future Health 

Human cytomegalovirus (HCMV) is the most common viral infection transmitted from the pregnant women to the fetus and the leading infectious cause of congenital neurological disease. The objective of the project is to identify maternal antibodies that are the most efficient at preventing the transmission of HCMV and the least likely to cause placental inflammation and fetal injury. The identification of such antibodies will have a considerable impact on the development of new vaccines and therapies against congenital HCMV infection and potentially also against other pathogens transmitted to the fetus such as the Zika virus.

CMV 2019

Birmingham, Alabama, April 7-11 2019

Annual CYMAF steering committee meeting

Pavia, September 23 2019


@ all right reserved to CYMAF consortium